Nykredit A/S’s Globus Medical GMED Stock Holding History

Nykredit A/S’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$330K	Buy	+4,179	New	+$355K	﹤0.01%	831

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Nykredit A/S's GMED Position: Q2 2026 in Review

Nykredit A/S opened a new position in Globus Medical (GMED) in Q2 2026: 4,179 shares worth $330K. The stake represents ﹤0.01% of the portfolio and ranks #831 among its holdings.

486 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Nykredit A/S held 4,179 shares of Globus Medical worth $330K as of Q2 2026.
Globus Medical was a new Nykredit A/S position in Q2 2026.
Globus Medical made up ﹤0.01% of Nykredit A/S's portfolio in Q2 2026, its #831 holding.
486 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.